Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA Management Board: highlights of October 2023 meeting 6 Οκτώβριος 2023NewsCorporate Revised transparency rules for the EU Clinical Trials Information System (CTIS) 6 Οκτώβριος 2023News EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna 5 Οκτώβριος 2023NewsHumanMedicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023 29 Σεπτέμβριος 2023NewsHumanPharmacovigilanceReferrals EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep 28 Σεπτέμβριος 2023NewsHumanMedicines Towards a permanent collaboration framework for EMA and Health Technology Assessment bodies 15 Σεπτέμβριος 2023NewsHuman Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15 Σεπτέμβριος 2023NewsHumanCOVID-19MedicinesReferrals Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 14 Σεπτέμβριος 2023NewsHumanCOVID-19Medicines PRAC recommends new measures to avoid topiramate exposure in pregnancy 1 Σεπτέμβριος 2023NewsHumanReferrals Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 August 2023 1 Σεπτέμβριος 2023NewsHumanPharmacovigilanceReferrals 1 … 27 28 29 30 31 Page 31 of 384 32 33 34 35 … 384
EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna 5 Οκτώβριος 2023NewsHumanMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023 29 Σεπτέμβριος 2023NewsHumanPharmacovigilanceReferrals
EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep 28 Σεπτέμβριος 2023NewsHumanMedicines
Towards a permanent collaboration framework for EMA and Health Technology Assessment bodies 15 Σεπτέμβριος 2023NewsHuman
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15 Σεπτέμβριος 2023NewsHumanCOVID-19MedicinesReferrals
Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 14 Σεπτέμβριος 2023NewsHumanCOVID-19Medicines
PRAC recommends new measures to avoid topiramate exposure in pregnancy 1 Σεπτέμβριος 2023NewsHumanReferrals
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 August 2023 1 Σεπτέμβριος 2023NewsHumanPharmacovigilanceReferrals